ArticleWorld journal of gastroenterology2015

β-escin reverses multidrug resistance through inhibition of the GSK3β/β-catenin pathway in cholangiocarcinoma.

Gui-Li Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.